Early research (Phase 1)Study completedNCT04100642What this trial is testingA Phase I Clinical Study of Hemay808Who this might be right forSafety Issues Tianjin Hemay Pharmaceutical Co., Ltd 42
Large-scale testing (Phase 3)Study completedNCT03912259What this trial is testingEvaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis Sanofi 165
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07598383What this trial is testingA Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic DermatitisWho this might be right forAtopic Dermatitis Jiangsu vcare pharmaceutical technology co., LTD 120
Early research (Phase 1)Study completedNCT05461456What this trial is testingBioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%Who this might be right forAtopic DermatitisAtopic Dermatitis EczemaAtopic Rash+9 more OrchestratePharma GmbH 12
Large-scale testing (Phase 3)Study completedNCT02118766What this trial is testingSafety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic DermatitisWho this might be right forDermatitis, Atopic Pfizer 763
Early research (Phase 1)Study completedNCT01614756What this trial is testingA Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic DermatitisWho this might be right forHealthy Subjects and Atopic Dermatitis Subjects Bristol-Myers Squibb 93
Not applicableActive Not RecruitingNCT05669794What this trial is testingAn Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real WorldWho this might be right forAtopic Dermatitis AbbVie 300
Large-scale testing (Phase 3)WithdrawnNCT04666675What this trial is testingOral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in BrazilWho this might be right forAtopic Dermatitis (AD) AbbVie
Testing effectiveness (Phase 2)Study completedNCT02525094What this trial is testingPhase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic DermatitisWho this might be right forAtopic Dermatitis MedImmune LLC 113
Testing effectiveness (Phase 2)Looking for participantsNCT07216027What this trial is testingLearn About Study Medicine Called PF-08049820 in People With EczemaWho this might be right forAtopic DermatitisEczema, Atopic Pfizer 165
Large-scale testing (Phase 3)Study completedNCT05369403What this trial is testingLebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With DupilumabWho this might be right forAtopic Dermatitis Eli Lilly and Company 86
Testing effectiveness (Phase 2)Looking for participantsNCT06524635What this trial is testingAssess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of LutikizumabWho this might be right forHidradenitis SuppurativaAtopic Dermatitis AbbVie 60
Early research (Phase 1)Study completedNCT02148744What this trial is testingSafety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic DermatitisWho this might be right forAllergic RhinitisAllergic ConjunctivitisAtopic Dermatitis Xencor, Inc. 72
Early research (Phase 1)Study completedNCT07172321What this trial is testingLearn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy AdultsWho this might be right forAtopic Dermatitis Pfizer 12
Testing effectiveness (Phase 2)Study completedNCT05906628What this trial is testingTopical Ruxolitinib Evaluation in Chronic Hand EczemaWho this might be right forHand Eczema Incyte Corporation 186
Large-scale testing (Phase 3)Not Yet RecruitingNCT06884891What this trial is testingA Phase Ⅲ Comparative Study of QL2108 to Dupixent®Who this might be right forAtopic Dermatitis Qilu Pharmaceutical Co., Ltd. 520
Large-scale testing (Phase 3)Study completedNCT05032859What this trial is testingTapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)Who this might be right forAtopic Dermatitis Organon and Co 406
Early research (Phase 1)Study completedNCT02334787What this trial is testingTrial of OPA-15406 Ointment in Healthy Adult Male SubjectsWho this might be right forAtopic Dermatitis Otsuka Pharmaceutical Co., Ltd. 32
Post-approval studies (Phase 4)Study completedNCT00693693What this trial is testingAdherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic DermatitisWho this might be right forAtopic Dermatitis Wake Forest University 26
Large-scale testing (Phase 3)Study completedNCT03661138What this trial is testingEvaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis AbbVie 272